Rocket Lab Q1 revenue up 69% YoY; Q2 guidance $105-110M; Neutron delayed to mid-2025

Rocket Lab Corp

2024-Q1 EPS reported -$0.09 revenue$92,767,000

Q1 2024 revenue grew 69% year-on-year; closed quarter with over $1 billion in backlog.
Q2 2024 guidance: revenue $105-110M, GAAP gross margin 24-26%, adjusted EBITDA loss $23-25M.
Neutron rocket first flight adjusted to no earlier than mid-2025 after first Archimedes engine assembly.
Post-quarter awarded $32M Victus Haze and $14.49M STP launch contracts from U.S. Space Force.
Space Development Agency $515M constellation contract (18 satellites) program kick-off completed.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.4

Rocket Lab Corp reported financial results for first quarter ended March 31, 2024.

Period: first quarter ended March 31, 2024
Result: reported results

Exact text from the filing

Rocket Lab USA, Inc. (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a global leader in launch services and space systems, today shared the financial results for fiscal first quarter ended March 31, 2024.

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Rocket Lab Corp reported second quarter of 2024 results: revenue between $105 million and $110 million. Guidance initiated.

Period: second quarter of 2024
Revenue: between $105 million and $110 million
Guidance: initiated
Result: guidance update

Exact text from the filing

For the second quarter of 2024, Rocket Lab expects: • Revenue between $105 million and $110 million.

View on SEC.gov

710 earnings releases filed in the last 30 days. Browse all earnings releases →

Rocket Lab Corp filing history →

Source: SEC EDGAR

accession 0000950170-24-053620

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.